More Like this

1. Size-Dependent Drug Loading, Gene Complexation, Cell Uptake, and Transfection of a Novel Dendron-Lipid Nanoparticle for Drug/Gene Co-delivery

   https://doi.org/10.1021/acs.biomac.1c00541  

   Nair, Ashita ; Bu, Jiyoon ; Bugno, Jason ; Rawding, Piper A. ; Kubiatowicz, Luke J. ; Jeong, Woo-jin ; Hong, Seungpyo ( September 2021 , Biomacromolecules)
2. Shaping nanoparticle diffusion through biological barriers to drug delivery

   https://doi.org/10.1016/j.jciso.2021.100025  

   Lee, Benjamin J. ; Cheema, Yahya ; Bader, Shahed ; Duncan, Gregg A. ( December 2021 , JCIS Open)
3. Preserving and enhancing mitochondrial function after stroke to protect and repair the neurovascular unit: novel opportunities for nanoparticle-based drug delivery

   https://doi.org/10.3389/fncel.2023.1226630  

   Novorolsky, Robyn J. ; Kasheke, Gracious D. ; Hakim, Antoine ; Foldvari, Marianna ; Dorighello, Gabriel G. ; Sekler, Israel ; Vuligonda, Vidyasagar ; Sanders, Martin E. ; Renden, Robert B. ; Wilson, Justin J. ; et al ( July 2023 , Frontiers in Cellular Neuroscience)

   The neurovascular unit (NVU) is composed of vascular cells, glia, and neurons that form the basic component of the blood brain barrier. This intricate structure rapidly adjusts cerebral blood flow to match the metabolic needs of brain activity. However, the NVU is exquisitely sensitive to damage and displays limited repair after a stroke. To effectively treat stroke, it is therefore considered crucial to both protect and repair the NVU. Mitochondrial calcium (Ca²⁺) uptake supports NVU function by buffering Ca²⁺and stimulating energy production. However, excessive mitochondrial Ca²⁺uptake causes toxic mitochondrial Ca²⁺overloading that triggers numerous cell death pathways which destroy the NVU. Mitochondrial damage is one of the earliest pathological events in stroke. Drugs that preserve mitochondrial integrity and function should therefore confer profound NVU protection by blocking the initiation of numerous injury events. We have shown that mitochondrial Ca²⁺uptake and efflux in the brain are mediated by the mitochondrial Ca²⁺uniporter complex (MCU_cx) and sodium/Ca²⁺/lithium exchanger (NCLX), respectively. Moreover, our recent pharmacological studies have demonstrated that MCU_cxinhibition and NCLX activation suppress ischemic and excitotoxic neuronal cell death by blocking mitochondrial Ca²⁺overloading. These findings suggest that combining MCU_cxinhibition with NCLX activation should markedly protect the NVU. In terms of promoting NVU repair, nuclear hormone receptor activation is a promising approach. Retinoid X receptor (RXR) and thyroid hormone receptor (TR) agonists activate complementary transcriptional programs that stimulate mitochondrial biogenesis, suppress inflammation, and enhance the production of new vascular cells, glia, and neurons. RXR and TR agonism should thus further improve the clinical benefits of MCU_cxinhibition and NCLX activation by increasing NVU repair. However, drugs that either inhibit the MCU_cx, or stimulate the NCLX, or activate the RXR or TR, suffer from adverse effects caused by undesired actions on healthy tissues. To overcome this problem, we describe the use of nanoparticle drug formulations that preferentially target metabolically compromised and damaged NVUs after an ischemic or hemorrhagic stroke. These nanoparticle-based approaches have the potential to improve clinical safety and efficacy by maximizing drug delivery to diseased NVUs and minimizing drug exposure in healthy brain and peripheral tissues.

    

   more » « less
4. Nanoparticle-mediated targeted drug delivery for breast cancer treatment

   https://doi.org/10.1016/j.bbcan.2019.04.006  

   Liyanage, Piumi Y. ; Hettiarachchi, Sajini D. ; Zhou, Yiqun ; Ouhtit, Allal ; Seven, Elif S. ; Oztan, Cagri Y. ; Celik, Emrah ; Leblanc, Roger M. ( April 2019 , Biochimica et Biophysica Acta (BBA) - Reviews on Cancer)
5. Targeting Lymphatics for Nanoparticle Drug Delivery

   https://doi.org/10.3389/fphar.2022.887402  

   McCright, Jacob ; Naiknavare, Ritika ; Yarmovsky, Jenny ; Maisel, Katharina ( June 2022 , Frontiers in Pharmacology)

   The lymphatics transport material from peripheral tissues to lymph nodes, where immune responses are formed, before being transported into systemic circulation. With key roles in transport and fluid homeostasis, lymphatic dysregulation is linked to diseases, including lymphedema. Fluid within the interstitium passes into initial lymphatic vessels where a valve system prevents fluid backflow. Additionally, lymphatic endothelial cells produce key chemokines, such as CCL21, that direct the migration of dendritic cells and lymphocytes. As a result, lymphatics are an attractive delivery route for transporting immune modulatory treatments to lymph nodes where immunotherapies are potentiated in addition to being an alternative method of reaching systemic circulation. In this review, we discuss the physiology of lymphatic vessels and mechanisms used in the transport of materials from peripheral tissues to lymph nodes. We then summarize nanomaterial-based strategies to take advantage of lymphatic transport functions for delivering therapeutics to lymph nodes or systemic circulation. We also describe opportunities for targeting lymphatic endothelial cells to modulate transport and immune functions. 

   more » « less